|
Volumn 71, Issue 15, 1997, Pages 54-56
|
Drugs & money. In the high-stakes hunt for blockbuster pharmaceuticals, companies are pouring billions each year into R & D--with no guarantee that their products will ultimately pass FDA scrutiny.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARTICLE;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG SCREENING;
ECONOMICS;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
UNITED STATES;
DRUG APPROVAL;
DRUG EVALUATION;
DRUG INDUSTRY;
RESEARCH SUPPORT;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 0031554651
PISSN: 10688838
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|